A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors (Q43091672)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 April 2010
edit
Language Label Description Also known as
English
A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors
scientific article published on 20 April 2010

    Statements

    A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit